Summary:
A clinical research study evaluating the efficacy, safety, and tolerability of Cariprazne as an add-on treatment to current Anti-depressant for the treatment of Major Depressive Disorder in individuals who are still experiencing symptoms of depression on their current anti-depressant medication. The study duration is up to 12 weeks, with seven in-person visits.
To be eligible for this study, the participant must:
- Be 18-65 years of age and in good general health
- Have a diagnosis of major depressive disorder
- Currently be on an anti-pressant for at least 6 weeks and have had an inadequate response.
Qualified Participants May Receive:
- The study medication
- a pharmacy card to pay for your current anti-depressant medication during the trial
- study related procedures at no cost.